glp 1 drug liraglutide may protect against dementia Older GLP-1 help brains of Alzheimer's patients Generic Liraglutide Approved, Marking First

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

ADDITIONAL DETAILS: Live Probiotics, Prebiotic Fiber, and a Key Postbiotic for Daily Support

This is the unlikely journey from desert predator to medical marvel.

A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimers disease, though more research is needed.

See how GLP-1s are reshaping diabetes & obesity care.

Allulose is not a GLP-1 agonist, but emerging research suggests it may modulate glucose metabolism and GLP-1 secretion in ways that merit clinical attention